The impact of illicit drug use and substance abuse treatment on adherence to HAART

Abstract High levels of adherence to highly active antiretroviral therapy (HAART) are essential for virologic suppression and longer survival in patients with HIV. We examined the effects of substance abuse treatment, current versus former substance use, and hazardous/binge drinking on adherence to HAART. During 2003, 659 HIV patients on HAART in primary care were interviewed. Adherence was defined as ≥95% adherence to all antiretroviral medications. Current substance users used illicit drugs and/or hazardous/binge drinking within the past six months, while former users had not used substances for at least six months. Logistic regression analyses of adherence to HAART included demographic, clinical and substance abuse variables. Sixty-seven percent of the sample reported 95% adherence or greater. However, current users (60%) were significantly less likely to be adherent than former (68%) or never users (77%). In multivariate analysis, former users in substance abuse treatment were as adherent to HAART as never users (Adjusted Odds Ratio (AOR)=0.82; p>0.5). In contrast, former users who had not received recent substance abuse treatment were significantly less adherent than never users (AOR=0.61; p=0.05). Current substance users were significantly less adherent than never users, regardless of substance abuse treatment (p<0.01). Substance abuse treatment interacts with current versus former drug use status to affect adherence to HAART. Substance abuse treatment may improve HAART adherence for former substance users.

[1]  D. Rumball,et al.  Substance Use and Mental Health , 2008 .

[2]  J. Fleishman,et al.  Use of complementary and alternative medicines among a multistate, multisite cohort of people living with HIV/AIDS , 2007, HIV medicine.

[3]  W. Hauck,et al.  Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users , 2003, Journal of General Internal Medicine.

[4]  Joseph Conigliaro,et al.  Problem drinking and medication adherence among persons with HIV infection , 2001, Journal of General Internal Medicine.

[5]  Richard D Moore,et al.  High Rates of Primary Mycobacterium avium Complex and Pneumocystis jiroveci Prophylaxis in the United States , 2005, Medical care.

[6]  Richard D Moore,et al.  Racial and Gender Disparities in Receipt of Highly Active Antiretroviral Therapy Persist in a Multistate Sample of HIV Patients in 2001 , 2005, Journal of acquired immune deficiency syndromes.

[7]  N. Horton,et al.  Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment. , 2004, Addiction.

[8]  C. Sherbourne,et al.  Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. , 2003, The American journal of medicine.

[9]  B. Yip,et al.  Impaired Virologic Response to Highly Active Antiretroviral Therapy Associated With Ongoing Injection Drug Use , 2003, Journal of acquired immune deficiency syndromes.

[10]  M. Chesney,et al.  The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Sally C Morton,et al.  The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. , 2002, Journal of studies on alcohol.

[12]  V. Johnson,et al.  Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370 , 2001, Antiviral therapy.

[13]  R. Grant,et al.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users , 2002, Journal of General Internal Medicine.

[14]  Richard D Moore,et al.  Detrimental Effects of Continued Illicit Drug Use on the Treatment of HIV‐1 Infection , 2001, Journal of acquired immune deficiency syndromes.

[15]  R. Chaisson,et al.  Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy , 2001, AIDS.

[16]  E. Navas,et al.  Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes. , 2001, AIDS.

[17]  Susan Swindells,et al.  Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection , 2000, Annals of Internal Medicine.

[18]  J. Walkup,et al.  Drug abuse, methadone treatment, and health services use among injection drug users with AIDS. , 2000, Drug and alcohol dependence.

[19]  A. Wu,et al.  Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments , 2000, AIDS care.

[20]  D. Richman,et al.  Predictors of Self‐Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens , 2000, Journal of acquired immune deficiency syndromes.

[21]  F. Hecht,et al.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population , 2000, AIDS.

[22]  J. Moatti,et al.  Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment , 2000, AIDS.